MedTrace Logo

The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study

NCT01899235 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2014-03-18

No results posted yet for this study

Summary

A randomised open-label pilot study to assess the safety and efficacy of treatment with a drug eluting balloon alone in coronary de novo lesions). Elective patients requiring PCI to coronary de novo lesions in vessels 2.5 mm - 4.0 mm.

Conditions

  • Stable Angina
  • Coronary Stenosis

Interventions

DEVICE

drug eluting balloon

DEVICE

drug eluting stent

Sponsors & Collaborators

  • Aachen Resonance GmbH

    collaborator INDUSTRY

  • Aalborg University Hospital

    lead OTHER

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01899235 on ClinicalTrials.gov